Clinical trial
Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic…
NCT00187005 · St. Jude Children's Research Hospital, Other · Terminated
Key facts
| NCT number | NCT00187005 |
|---|---|
| Title | Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
| Official title | Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | Prednisone, Dexamethasone, Vincristine, Daunorubicin, PEG-L-asparaginase, L-asparaginase, Methotrexate, Idarubicin, Etoposide, Cyclophosphamide and 2 more |
| Enrollment | 53 |
| Start date | Jul 1, 1998 |
| Primary completion | Jul 1, 2002 |
| Completion | Jul 1, 2002 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 30, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: